Industry News

Novartis announces new division heads of Alcon, Sandoz

Jeff George will succeed Kevin Buehler as Division Head of Alcon, effective May 1, according to a press release from Novartis.

Buehler is retiring from the company and will provide management and strategic support on the Alcon business as part of the planned transition, the release said.

Richard Francis, after 13 years at Biogen Idec, will replace George as Division Head of Sandoz.

“The appointments of Jeff George as the new Division Head of Alcon and of Richard Francis as new Division Head of Sandoz place two strong leaders at the helm of two leading Novartis businesses. These new leaders will set the direction for the next phase of growth for our eye care and generics businesses, two of our core growth engines,” Joseph Jimenez, CEO of Novartis, said in the release.

Jeff George will succeed Kevin Buehler as Division Head of Alcon, effective May 1, according to a press release from Novartis.

Buehler is retiring from the company and will provide management and strategic support on the Alcon business as part of the planned transition, the release said.

Richard Francis, after 13 years at Biogen Idec, will replace George as Division Head of Sandoz.

“The appointments of Jeff George as the new Division Head of Alcon and of Richard Francis as new Division Head of Sandoz place two strong leaders at the helm of two leading Novartis businesses. These new leaders will set the direction for the next phase of growth for our eye care and generics businesses, two of our core growth engines,” Joseph Jimenez, CEO of Novartis, said in the release.